A Role for the Mitochondrial Protein Mrpl44 in Maintaining OXPHOS Capacity

PLoS One. 2015 Jul 29;10(7):e0134326. doi: 10.1371/journal.pone.0134326. eCollection 2015.

Abstract

We identified Mrpl44 in a search for mammalian proteins that contain RNase III domains. This protein was previously found in association with the mitochondrial ribosome of bovine liver extracts. However, the precise Mrpl44 localization had been unclear. Here, we show by immunofluorescence microscopy and subcellular fractionation that Mrpl44 is localized to the matrix of the mitochondria. We found that it can form multimers, and confirm that it is part of the large subunit of the mitochondrial ribosome. By manipulating its expression, we show that Mrpl44 may be important for regulating the expression of mtDNA-encoded genes. This was at the level of RNA expression and protein translation. This ultimately impacted ATP synthesis capability and respiratory capacity of cells. These findings indicate that Mrpl44 plays an important role in the regulation of the mitochondrial OXPHOS capacity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / biosynthesis
  • Animals
  • Cattle
  • Cell Line
  • DNA, Mitochondrial / genetics
  • DNA, Mitochondrial / metabolism
  • Gene Expression Regulation
  • Gene Knockdown Techniques
  • HEK293 Cells
  • Humans
  • Mice
  • Mitochondria, Liver / metabolism
  • Mitochondrial Proteins / chemistry
  • Mitochondrial Proteins / genetics
  • Mitochondrial Proteins / metabolism*
  • Mitochondrial Ribosomes / metabolism
  • NIH 3T3 Cells
  • Oxidative Phosphorylation
  • Oxygen Consumption
  • Protein Multimerization
  • Ribonuclease III / chemistry
  • Ribonuclease III / genetics
  • Ribonuclease III / metabolism
  • Ribosomal Proteins / chemistry
  • Ribosomal Proteins / genetics
  • Ribosomal Proteins / metabolism

Substances

  • DNA, Mitochondrial
  • Mitochondrial Proteins
  • Ribosomal Proteins
  • Adenosine Triphosphate
  • Ribonuclease III

Grants and funding

This work was funded by grants from the National Health and Medical Research Council, Australia (#1004541 and #1042211 to MMWC; #1042582 to GTB; #1016647 to JGZ), MMWC is an Australian Research Council QEII Fellow, GTB is an Australian Research Council Future Fellow, JHCY was supported by the Melbourne International Research Scholarship and Melbourne International Fee Remission Scholarship. This work was made possible through Victorian State Government Operational Infrastructure Support, Australian National Health and Medical Research Council Research Institute Infrastructure Support Scheme and the Australian Mitochondrial Disease Foundation.